News

Filter

Current filters:

Feraheme

FDA cites insufficient information in response to AMAG’s Feraheme application

FDA cites insufficient information in response to AMAG’s Feraheme application

23-01-2014

US drug company AMAG Pharmaceuticals (Nasdaq: AMAG) has received a complete response letter from the…

AMAG PharmaceuticalsFerahemeHematologyNephrology and HepatologyPharmaceuticalRegulationUSA

3SBio licenses rights to Panacor Nephoxil for China

09-02-2010

Chinese biotechnology firm 3SBio has entered into a collaboration and license agreement with Taiwan-headquartered…

Amino AcidsAsia-PacificFerahemeFerumoxytol InjectionInjectionLicensingPharmaceuticalPhysostigmine Salicylate

COMPANY SPOTLIGHT

Menarini

Back to top